呼吸器・免疫内科学

• ホーム
• 研究業績
• Case report

Case report

2019年

• Unique Case of Pseudoprogression Manifesting as Lung Cavitation After Pembrolizumab Treatment.
  Masuhiro K, Shiroyama T, Nagatomo I, Kumanogoh A.
  J Thorac Oncol. 2019 May;14(5):e108-e109.

2018年

• OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE.
  Mizuno Y, Nishide M, Wakabayashi T, Nishida K, Kumanogoh A.
  Ann Rheum Dis. 2018 Nov 28.

2017年

• Systemic cardiovascular inflammation associated with autoimmune disease.
  Koga M, Kawarada O, Yagyu T, Ishibashi-Ueda H, Hirano T, Noguchi T, Yasuda S.
  Vasc Med. 2017 Dec 1.
• Tracheobronchopathia Osteochondroplastica: A Cause of Difficult Tracheal Intubation.
  Matsuki T, Takeda Y, Kida H, Kumanogoh A.
  Intern Med. 2017 Nov 1.
• Minimal neonatal transfer of certolizumab pegol in a Japanese patient with rheumatoid arthritis.
  Morita T, Fujimoto K, Shima Y, Ogata A, Kumanogoh A.
  Ann Rheum Dis. 2017 Sep 22. pii: annrheumdis-2017-212366.
• Rapid intracranial response to osimertinib, without radiotherapy, in nonsmall cell lung cancer patients harboring the EGFR T790M mutation: Two Case Reports.
  Koba T, Kijima T, Takimoto T, Hirata H, Naito Y, Hamaguchi M, Otsuka T, Kuroyama M, Nagatomo I, Takeda Y, Kida H, Kumanogoh A.
  Medicine (Baltimore). 2017 Feb;96(6):e6087.
• Serum anti-citrullinated protein antibodies of a mother with rheumatoid arthritis pass through the placenta but do not cause arthritis in her neonate.
  Morita T, Shima Y, Kakigano A, Ogata A, Kumanogoh A.
  Scand J Rheumatol. 2017 Jan;46(1):85-86.

2015年

• Dapsone hypersensitivity syndrome-related lung injury without eosinophilia in the bronchoalveolar lavage fluid.
  Kinehara Y, Kijima T, Inoue K, Hirata H, Takeuchi Y, Fukushima K, Hayama Y, Higashiguchi M, Morimura O, Miyake K, Minami T, Nagatomo I, Takeda Y, Kida H, Kumanogoh A.
  Intern Med. 2015;54(7):827-31. Epub 2015 Apr 1.

2014年

• Development of microscopic polyangiitis-related pulmonary fibrosis in a patient with autoimmune pulmonary alveolar proteinosis.
  Kinehara Y, Kida H, Inoue Y, Hirose M, Nakabayashi A, Takeuchi Y, Hayama Y, Fukushima K, Hirata H, Inoue K, Minami T, Nagatomo I, Takeda Y, Funakoshi T, Kijima T, Kumanogoh A.
  BMC Pulm Med. 2014 Nov 4;14:172.
• Rapidly progressive pneumonia caused by Cryptococcus neoformans in the patient of granulomatosis with polyangiitis.
  Nakabayashi A, Seki M, Hirano T, Hirata H, Tomono K, Kumanogoh A.
  Respir Med Case Rep. 2014 Aug 8;13:13-5.

2013年

• Drug-induced thrombotic thrombocytopenic purpura successfully treated with recombinant human soluble thrombomodulin.
  Nishijima Y, Hirata H, Himeno A, Kida H, Matsumoto M, Takahashi R, Otani Y, Inoue K, Nagatomo I, Takeda Y, Kijima T, Tachibana I, Fujimura Y, Kumanogoh A.
  Intern Med. 2013;52(10):1111-4. Epub 2013 May 15.
• A 46-year-old woman with atelectasis from an endobronchial tumor.
  Uenami T, Kijima T, Ayata M, Hayama Y, Tsuruta N, Saito Y, Niju T, Higaki N, Ikeda T.
  Chest. 2013 Apr;143(4):1170-1173.

2012年

• Fulminant pneumonia caused by nontypable haemophilus influenzae.
  Fukushima K, Doi H, Hamaguchi S, Tomono K.
  Intern Med. 2013;52(15):1755. Epub 2012 Mar 1.
• Vaccination with WT-1 (Wilms' tumor gene-1) peptide and BCG-CWS in melanoma.
  Nishioka M, Tanemura A, Nishida S, Nakano A, Tsuboi A, Oji Y, Oka Y, Azuma I, Sugiyama H, Katayama I.
  Eur J Dermatol. 2012 Mar-Apr;22(2):258-9.
• WT1 peptide therapy for a patient with chemotherapy-resistant salivary gland cancer.
  Shirakata T, Oka Y, Nishida S, Hosen N, Tsuboi A, Oji Y, Murao A, Tanaka H, Nakatsuka S, Inohara H, Sugiyama H.
  Anticancer Res. 2012 Mar;32(3):1081-5.

2011年

• Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab.
  Ogata A, Umegaki N, Katayama I, Kumanogoh A, Tanaka T.
  Joint Bone Spine. 2012 Jan;79(1):85-7. Epub 2011 Oct 1.
• A case of Behcet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
  Hirano T, Ohguro N, Hohki S, Hagihara K, Shima Y, Narazaki M, Ogata A, Yoshizaki K, Kumanogoh A, Kishimoto T, Tanaka T.
  Mod Rheumatol. 2012 Apr;22(2):298-302. Epub 2011 Jul 12.
• Safe and successful treatment with erlotinib after gefitinib-induced hepatotoxicity: difference in metabolism as a possible mechanism.
  Kijima T, Shimizu T, Nonen S, Furukawa M, Otani Y, Minami T, Takahashi R, Hirata H, Nagatomo I, Takeda Y, Kida H, Goya S, Fujio Y, Azuma J, Tachibana I, Kawase I.
  J Clin Oncol. 2011 Jul 1;29(19):e588-90. Epub 2011 Apr 18.
• Recurrent allergic bronchopulmonary aspergillosis in a patient with rheumatoid arthritis treated with etanercept and tocilizumab.
  Honda H, Kida H, Yoshida M, Tomita T, Fujii M, Ihara S, Goya S, Tachibana I, Kawase I.
  Mod Rheumatol. 2011 Dec;21(6):660-4. Epub 2011 Apr 7.
• Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorated clinical symptoms and MRI findings of a patient with ankylosing spondylitis.
  Shima Y, Tomita T, Ishii T, Morishima A, Maeda Y, Ogata A, Kishimoto T, Tanaka T.
  Mod Rheumatol. 2011 Aug;21(4):436-9. Epub 2011 Feb 9.
• Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab.
  Nishida S, Kawasaki T, Kashiwagi H, Morishima A, Hishitani Y, Kawai M, Hirano T, Ishii T, Hagihara K, Shima Y, Narazaki M, Ogata A, Oka Y, Kishimoto T, Tanaka T.
  Mod Rheumatol. 2011 Aug;21(4):420-2. Epub 2011 Jan 15.